Geographic Variation in Prescription Patterns of Parkinson's Disease Medications.
作者信息
Bruno Michiko K, Watanabe Gina, Ishikawa Kyle, Chen John J, Gao Fay, Nakagawa Kazuma, Taira Deborah
机构信息
Neuroscience Institute, The Queen's Medical Center, Honolulu, Hawaii, USA.
John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
出版信息
Mov Disord. 2022 Mar;37(3):646-648. doi: 10.1002/mds.28880. Epub 2021 Dec 3.
Abstract
摘要
相似文献
1
Geographic Variation in Prescription Patterns of Parkinson's Disease Medications.帕金森病药物处方模式的地域差异。
Mov Disord. 2022 Mar;37(3):646-648. doi: 10.1002/mds.28880. Epub 2021 Dec 3.
2
Seasonal temperature is associated with Parkinson's disease prescriptions: an ecological study.季节温度与帕金森病处方有关：一项生态学研究。
Int J Biometeorol. 2017 Dec;61(12):2205-2211. doi: 10.1007/s00484-017-1427-9. Epub 2017 Aug 30.
3
Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.韩国老年痴呆症患者抗胆碱能药物的处方模式及其相关因素。
Int J Clin Pharm. 2013 Oct;35(5):711-8. doi: 10.1007/s11096-013-9793-9. Epub 2013 May 25.
4
Potentially inappropriate prescriptions of antipsychotic and anticholinergic drugs in patients with Parkinson's disease.帕金森病患者潜在不合理的抗精神病药和抗胆碱能药物处方。
Neurodegener Dis Manag. 2021 Oct;11(5):361-371. doi: 10.2217/nmt-2021-0021. Epub 2021 Sep 16.
5
Medications and their monitoring in Parkinson's disease in Dunedin.达尼丁帕金森病的药物治疗及其监测
N Z Med J. 1992 Jun 10;105(935):212-4.
6
[Mechanism of anti-aging therapy on Parkinson's disease].[抗衰老疗法对帕金森病的作用机制]
Zhongguo Zhong Yao Za Zhi. 2016 Jul;41(14):2680-2686. doi: 10.4268/cjcmm20161419.
7
Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease.帕金森病患者抗精神病药物使用的发生率、处方模式及决定因素。
Mov Disord. 2011 Aug 1;26(9):1663-9. doi: 10.1002/mds.23719. Epub 2011 May 31.
8
Prescription pattern and awareness of disease and treatment in patients of Parkinson's disease.帕金森病患者的用药模式以及对疾病和治疗的认知
Neurodegener Dis Manag. 2017 Oct;7(5):299-306. doi: 10.2217/nmt-2017-0020. Epub 2017 Oct 18.
9
Guidelines on exercise testing and prescription for patients at different stages of Parkinson's disease.帕金森病不同阶段患者的运动试验和运动处方指南。
Aging Clin Exp Res. 2021 Feb;33(2):221-246. doi: 10.1007/s40520-020-01612-1. Epub 2020 Jun 8.
10
Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.老年帕金森病患者痴呆治疗模式和明显处方错误。
JAMA Neurol. 2019 Jan 1;76(1):41-49. doi: 10.1001/jamaneurol.2018.2820.
引用本文的文献
1
Access to device-aided therapies in advanced Parkinson's disease: navigating clinician biases, patient preference, and prognostic uncertainty.在晚期帕金森病中获得器械辅助治疗：应对临床医生偏见、患者偏好和预后不确定性。
J Neural Transm (Vienna). 2023 Nov;130(11):1411-1432. doi: 10.1007/s00702-023-02668-9. Epub 2023 Jul 12.
2
Difference in rural and urban Medicare prescription pattern for Parkinson's disease in Hawai'i.夏威夷农村和城市地区帕金森病医疗保险处方模式的差异。
Clin Park Relat Disord. 2022 Apr 22;6:100144. doi: 10.1016/j.prdoa.2022.100144. eCollection 2022.
本文引用的文献
1
Geographic Variation in Neurologist Density and Neurologic Care in the United States.美国神经科医生密度与神经科医疗的地域差异。
Neurology. 2021 Jan 19;96(3):e309-e321. doi: 10.1212/WNL.0000000000011276. Epub 2020 Dec 23.
2
Factors Influencing Prescribing Decisions of Physicians: A Review.影响医生处方决策的因素：综述
Ethiop J Health Sci. 2018 Nov;28(6):795-804. doi: 10.4314/ejhs.v28i6.15.
3
'Levodopa Phobia': a review of a not uncommon and consequential phenomenon.“左旋多巴恐惧症”：一种常见且有重要影响的现象的综述
NPJ Parkinsons Dis. 2018 Oct 2;4:31. doi: 10.1038/s41531-018-0067-z. eCollection 2018.
4
International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.国际帕金森病和运动障碍学会循证医学综述：帕金森病运动症状治疗的最新进展。
Mov Disord. 2018 Aug;33(8):1248-1266. doi: 10.1002/mds.27372. Epub 2018 Mar 23.
5
Personalized medicine in Parkinson's disease: Time to be precise.帕金森病的个性化医疗：是时候做到精准了。
Mov Disord. 2017 Aug;32(8):1147-1154. doi: 10.1002/mds.27027. Epub 2017 Jun 12.
6
Neurologist-associated reduction in PD-related hospitalizations and health care expenditures.神经科医生相关的 PD 相关住院率和医疗支出降低。
Neurology. 2012 Oct 23;79(17):1774-80. doi: 10.1212/WNL.0b013e3182703f92. Epub 2012 Oct 10.
7
"Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease.“左旋多巴恐惧症”：帕金森病中一种新的医源性致残原因。
Neurology. 2005 Mar 8;64(5):923-4. doi: 10.1212/01.WNL.0000152880.77812.5B.
Zotero 插件